SCHEMBL22619982

SCHEMBL22619982

CCOC(=O)C(F)(F)C(=O)OCC.NC(=O)C(F)(F)C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.46
ALDH1A1 P00352 2/20 0.39
PKM P14618 3/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CYP4F2 P78329 2/20 0.36
CYP4A11 Q02928 2/20 0.36
THRB P10828 1/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
POLB P06746 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SOAT1 P35610 1/20 0.36
HTT P42858 1/20 0.35
MAPT P10636 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1979744 0.89 ALDH1A1 (0.48) ALOX15ALDH1A1PKMKDM4EMEN1
SCHEMBL14403192 0.78 ALOX15 (0.46) ALOX15ALDH1A1PKMKDM4EMEN1
SCHEMBL14403317 0.78 ALOX15 (0.46) ALOX15ALDH1A1PKMKDM4EMEN1
SCHEMBL28803958 0.78 ALDH1A1 (0.39) ALOX15ALDH1A1PKMKDM4EMEN1
SCHEMBL11204020 0.77 CYP4F2 (0.42) ALOX15ALDH1A1PKMKDM4EMEN1
SCHEMBL125138 0.77 ALDH1A1 (0.46) ALOX15ALDH1A1PKMKDM4EMEN1
Water SCHEMBL4000009 0.77 MEN1 (0.44) ALOX15ALDH1A1PKMKDM4EMEN1
SCHEMBL3372776 0.77 ALDH1A1 (0.42) ALOX15ALDH1A1PKMKDM4EMEN1
SCHEMBL29083077 0.77 ALDH1A1 (0.42) ALOX15ALDH1A1PKMKDM4EMEN1
SCHEMBL29756467 0.77 ALDH1A1 (0.37) ALOX15ALDH1A1PKMKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828305-B2 Nitrogenous heterocyclic compound, preparation method, intermediate, composition and use SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2020-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10828305-B2 Nitrogenous heterocyclic compound, preparation method, intermediate, composition and use ERBB2, EGFR, ERBB4 ALOX15 2841/4885ALDH1A1 3908/4885PKM 3224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.